Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase

In silico prediction of protein-protein interactions in human macrophages

Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785

Significance analysis of microarrays applied to the ionizing radiation response

Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., et al. (2001) · Nature Genetics · doi:10.1038/ng1201-365 · Cited by 4,109

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440

Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome

Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 2,141

The molecular biology of chronic myeloid leukemia

Deininger, M. W., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,654

The Biology of Chronic Myeloid Leukemia

Faderl, S. H., Talpaz, M., Estrov, Z. E., O'Brien, S. M., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,322

Intracellular signalling pathways activated by leptin

Frühbeck, G. (2005) · Biochemical Journal · doi:10.1042/bj20051578 · Cited by 851

Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton

Tapon, N. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80156-1 · Cited by 819

Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells

Gainsford, T., Willson, T. A., Metcalf, D., Handman, E., McFarlane, C., Ng, A. P., Nicola, N. A., Alexander, W. S., & Hilton, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14564 · Cited by 758

Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia

Schmidt, S. U., Gastl, G. A., & Wolf, D. G. F. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190801896194 · Cited by 7

Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies

Bris, Y. L., Costes, D., Bourgade, R., Guillaume, T., Péterlin, P., Garnier, A., Bourgeois, A. L., Chevallier, P., & Béné, M. C. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01747-x · Cited by 6

The PKR-Like Endoplasmic Reticulum Kinase Promotes the Dissemination of Myc-Induced Leukemic Cells

Gui, J., Katlinski, K. V., Koumenis, C., Diehl, J. A., & Fuchs, S. Y. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0002 · Cited by 6

Coexpression Pattern Analysis of NPM1-Associated Genes in Chronic Myelogenous Leukemia

Wang, F., Chan, L., Tsui, N. B. Y., Wong, S. C. C., Siu, P. M., Yip, S. P., & Yung, B. Y. (2015) · BioMed Research International · doi:10.1155/2015/610595 · Cited by 6

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Yang, H., Li, V., Park, S. J., Cheon, S. W., Lorant, A., Mazumder, A., Lee, J., Orlikova-Boyer, B., Cerella, C., Christov, C., et al. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01921-0 · Cited by 5

Novel Approach for Coexpression Analysis of E2F1–3 and MYC Target Genes in Chronic Myelogenous Leukemia

Wang, F., Chan, L., Cho, W. C. S., Tang, P., Yu, J. M., Shyu, C., Tsui, N. B. Y., Wong, S. C. C., Siu, P. M., Yip, S. P., et al. (2014) · BioMed Research International · doi:10.1155/2014/439840 · Cited by 5

Role of gene-expression profiling in chronic myeloid leukemia

Schmidt, S. U., & Wolf, D. G. F. (2009) · Expert Review of Hematology · doi:10.1586/17474086.2.1.93 · Cited by 5

Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment

Trojani, A., Pungolino, E. M., Rossi, G., D’Adda, M., Lodola, M., Camillo, B. D., Perego, A., Turrini, M., Orlandi, E. M., Borin, L. M., et al. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170209 · Cited by 5

Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study

Pungolino, E. M., D’Adda, M., Canal, G. D., Trojani, A., Perego, A., Elena, C., Lunghi, F., Turrini, M., Borin, L. M., Iurlo, A., et al. (2021) · European Journal Of Haematology · doi:10.1111/ejh.13680 · Cited by 4

Targeting the Chronic Myeloid Leukemia Stem Cell: A Paradigm for the Curative Treatment of Human Malignancies

Woolfson, A., & Jiang, X. (2011) · InTech eBooks · doi:10.5772/29354 · Cited by 4

Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients

Ricciardi, M. R., Salvestrini, V., Licchetta, R., Mirabilii, S., Forcato, M., Gugliotta, G., Salati, S., Castagnetti, F., Rosti, G., Breccia, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24938 · Cited by 4

Differential gene expression changes and their implication on the disease progression in patients with Chronic Myeloid Leukemia

Chandran, R. K., Geetha, N., Sakthivel, K. M., Kumar, R. S., Krishna, K. M. N. J., & Sreedharan, H. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.03.004 · Cited by 4

Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia

Wu, S., Lai, S., Lu, X.-J., Lai, H.-F., Chen, Y., Chen, P., Ho, C., Wu, Y., & Chiu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1173970 · Cited by 3

Acid Ceramidase, a Double-edged Sword in Cancer Aggression: A Minireview

Vethakanraj, H. S., Chandrasekaran, N., & Sekar, A. K. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666201223154621 · Cited by 3

Mechanisms Linking Obesity and Leukemia Prognosis

Mittelman, S. D., & Butturini, A. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2403-1_3 · Cited by 3

Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic Vulnerabilities

Tolland, M., Ross, D. M., White, D. L., Hughes, T. P., & Pagani, I. S. (2025) · Cancers · doi:10.3390/cancers17183033 · Cited by 2

FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Li, X., Zuo, S., Zhang, Y., Liu, Z., Shen, N., Ma, Q., Sun, M., Zhang, B., Li, M., Huang, H., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102686 · Cited by 2

Bone Marrow Adipocytes and Hematology: A Literature Review

Kriventsova, N. A., Shestopalov, A. M., & Tereshchenko, G. (2021) · International Journal of Biomedicine · doi:10.21103/article11(2)_ra2 · Cited by 2

Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic‐phase chronic myeloid leukemia treated with imatinib

Shima, H., Kiyokawa, N., Miharu, M., Tanizawa, A., Kurosawa, H., Watanabe, A., Ito, M., Tono, C., Yuza, Y., Muramatsu, H., et al. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26478 · Cited by 2

DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA

Güneş, B. A., Hekmatshoar, Y., Özkan, T., Bozkurt, S., Aydos, S., Büyükaşık, Y., Aladağ, E., & Sunguroğlu, A. (2023) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2023.008 · Cited by 2

Co-expression Pattern Analysis of miR-17-92 Target Genes in Chronic Myelogenous Leukemia

Wang, F., Meng, F., & Wang, L. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00167 · Cited by 2

Myeloproliferative masks of multiple myeloma: A review of literature and clinical case reports

Владимирович, Р. В., Евгеньевич, Г. А., Klodzinsky, A. A., Ivanova, T. V., Сатаева, М. С., & Gribanova, E. O. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh201789172-77 · Cited by 2

Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia

Paik, J. Y., Gajulapalli, S. R., Li, V., Park, S., Lee, Y., Orlikova-Boyer, B., Lorant, A., Christov, C., Kirsch, G., Kang, H. J., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119652 · Cited by 1

Network Clusters Analysis Based on Protein–Protein Interaction Network Constructed in Phosgene-Induced Acute Lung Injury

Liu, Z., Gao, F., Hou, L., Qian, Y., & Tian, R. (2013) · Lung · doi:10.1007/s00408-013-9493-1 · Cited by 1

Expression of miRNAs Associated with the AML1-ETO, CBFB-MYH1, PML-RARA and AF9-MLL Oncoproteins in Acute Myeloid Leukemia

(2016) · Journal of Human Anatomy & Physiology · doi:10.13188/2575-7563.1000003 · Cited by 1

Tyrosine Kinase level and White Blood Cells Count in Untreated and Treated Chronic Myelogenous Leukemia Patients with BCR ABL gene

(2016) · International Journal of Science and Research (IJSR) · doi:10.21275/v5i7.nov152895 · Cited by 1

Gene expression changes in normal haematopoietic cells

Lionberger, J. M., & Stirewalt, D. L. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.05.005 · Cited by 1

Defining novel therapeutic targets in chronic myeloid leukaemia stem cells : targeting self-renewal through hedgehog pathway inhibition

Irvine, D. A. (2013) · Enlighten: Theses (The University of Glasgow)

Investigating the SRC kinase HCK functions in Chronic Myelogenous Leukemia using chemical genetics methods.

Dumitrescu, T. P. (2009) · D-Scholarship@Pitt (University of Pittsburgh)

Análise da expressão gênica por microarrays de células-tronco hematopoéticas e mesenquimais de pacientes com esclerose múltipla

de Oliveira, G. L. V. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2013.tde-18032013-135704

STAT3 contributes to resistance towards BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance in chronic myeloid leukemia cells

Bewry, N. N. (2009) · Digital Commons - University of South Florida (University of South Florida)

Induced pluripotent stem cell model of chronic myeloid leukemia revealed olfactomedin 4 as a novel therapeutic target in leukemia stem cells

Suknuntha, K., Ishii, Y., Hu, K., Wang, J., Swanson, S. A., Stewart, R. M., Thomson, J. L., & Slukvin, I. I. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.05.066

Original Article Microarray Analysis Using a Limited Amount of Cells

Peterková, M., Koutná, I., Tesařová, L., Potěšilová, M., Kozubek, M., Hrabčáková, V., Klabusay, M., Doubek, M., & Mayer, J. (2008)

BIOLOGICAL MECHANISMS AND CLINICAL IMPLICATIONS OF BCR-ABL-INDUCED MITOCHONDRIAL OXIDATIVE STRESS AND CELL SURVIVAL IN CHRONIC MYELOID LEUKEMIA

Zhang, H. (2012) · Digital Commons-TMC (Texas Medical Center)

Molecular mechanisms for the progression of chronic myeloid leukemia

Marega, M. (2010) · BOA (University of Milano-Bicocca)

Genexpressionsanalysen der gesunden hämatopoetischen Stamm- und Progenitorzellen bei Patienten mit chronischer myeloischer Leukämie unter Therapie mit Imatinib

de Haas, R. J. (2010)

Prognostic significance of treatment response in CML in view of current recommendations for treatment and monitoring

von Bubnoff, N. C. C. (2011) · Therapeutic Advances in Hematology · doi:10.1177/2040620711402415 · Cited by 1

Identification and characterization of human CD34 + and CD34 dim/- neutrophil-committed progenitorsPreprint

Calzetti, F., Finotti, G., Tamassia, N., Bianchetto-Aguilera, F. M., Castellucci, M., Cavallini, C., Mattè, A., Gasperini, S., Benedetti, F. M., Bonifacio, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.30.442138

Faculty Opinions recommendation of Chronic myeloid leukemia stem cells.

Krause, D. S. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735836791.793583291

Additional file 2 of Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation

Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J.-Y., Paik, J. Y., Lee, Y., Siegel, D. M., Ross, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25751487

Additional file 6 of Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation

Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J.-Y., Paik, J. Y., Lee, Y., Siegel, D. M., Ross, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716147

Additional file 4 of Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation

Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J.-Y., Paik, J. Y., Lee, Y., Siegel, D. M., Ross, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716141

Additional file 5 of Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation

Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J.-Y., Paik, J. Y., Lee, Y., Siegel, D. M., Ross, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716144

Additional file 3 of Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation

Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J.-Y., Paik, J. Y., Lee, Y., Siegel, D. M., Ross, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716138

Additional file 1 of Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation

Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., Cerella, C., Schnekenburger, M., Lee, J.-Y., Paik, J. Y., Lee, Y., Siegel, D. M., Ross, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25751437

Targeting Cathepsin-G to Overcome Leukemic Stem Cell Persistence in Chronic MyeloidPreprint

Benjamin, E. S. B., Illangeswaran, R. S. S., Rajamani, B. M., Mohan, A., Rane, M. A., Abraham, A., Mathews, V., Velayudhan, S. R., & Balasubramanian, P. (2026) · Research Square · doi:10.21203/rs.3.rs-8580579/v1

Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells

Atef, B., El‐Ashwah, S., Saleh, L. M., Gawish, H., & Mabed, M. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06795-7

Signalisation des GTPases de la famille Rho dans les phénotypes migratoires induits par les différentes formes de Bcr-Abl

Rochelle, T. (2012) · theses.fr (ABES) · doi:10.70675/e67b5851za9c2z4fdbzb085zbbf123e60ef2

Toward an Improved Chronic Myelogenous Leukemia Treatment: Blocking the Stem Cell Factor–Mediated Innate Resistance With Anti–c-Kit Synthetic-Antibody Inhibitors

Bui, A. (2015) · HARVEST (University of Saskatchewan)

Molekulare Wirkmechanismen von Tyrosinkinase-Inhibitoren in der Therapie der chronischen myeloischen Leukämie

Brünnert, D. (2010) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Bruns, I., Czibere, A. G., Fischer, J., Steidl, U. G., Pechtel, S., Koch, A., Brünnert, D., Büst, S., Cadeddu, R., Kronenwett, R., et al. (2007) · Blood · doi:10.1182/blood.v110.11.3170.3170

Molecular Phenotype of Malignant CD34+ Hematopoietic Stem and Progenitor Cells in Chronic Myelogenous Leukemia.

Kronenwett, R., Blanco, E. D., Graef, T. T., Steidl, U. U., Kliszewski, S., Bruns, I., Neumann, F., Bork, S., Butterweck, U., Roes, N., et al. (2005) · Blood · doi:10.1182/blood.v106.11.2863.2863

Molecular signature and functional analysis of leukemic and normal CD34+ hematopoietic stem and progenitor cells

Blanco, E. D. (2008) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver

Distinct molecular phenotype of malignant CD34+ hematopoietic stem and progenitor cells in chronic myelogenous leukemia

Kronenwett, R., Butterweck, U., Steidl, U. U., Kliszewski, S., Neumann, F., Bork, S., Blanco, E. D., Roes, N., Graef, T. T., Brors, B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208596 · Cited by 59

Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls

Carrara, R. C. V., Fontes, A. M., Abraham, K., Orellana, M. D., Kashima, S. H., Palma, P. V. B., Panepucci, R. A., Zago, M. A., & Covas, D. T. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1751-x · Cited by 19